Jordan Gauthier, MD, MSc
The meaningful connections I make with patients are part of what I enjoy about this specialty. One of my favorite memories is bonding with a patient who was undergoing a bone marrow transplant. He was a talented engineer and would show me pictures of all the amazing objects he built. He also taught me all about Japanese dog breeds and, I hope, I was able to teach him about the workings of the immune system. Not only did we develop an easy rapport, but we learned from each other, and I was grateful I could accompany him on his journey.
I strive to be mindful of your life story beyond your disease, learning about your goals for care, your support system and what activities bring you joy. Depending on your interest and level of comfort, I like to share with you what’s going on beneath the surface of a symptom or disease process, discussing the biology of what’s happening so you know why you aren’t feeling well — or why you’re feeling better. As much as possible, I try to prepare you for what to expect during the treatment process so that you aren’t caught off guard by symptoms or side effects.
Specialty: Medical Oncology
Adult Blood and Marrow Transplantation, Cellular Immunotherapy
I am a hematologist-oncologist who specializes in treating blood cancers such as leukemia and lymphoma. My expertise includes caring for patients receiving blood and bone marrow transplantation (BMT) as well as immunotherapies.
Much of my research so far has been focused on improving outcomes for patients treated with BMT or chimeric antigen receptor (CAR) T-cell therapy. This cellular immunotherapy engineers T cells (a type of immune cell) to attack tumors. Through my work, I have identified factors that can help predict the success of CAR T-cell therapy for patients who have leukemia and lymphoma. My background also includes international research collaborations through the European Society for Blood and Marrow Transplantation.
This award recognizes talented scientists, physicians and nurses who are rising stars in the field of bone marrow transplantation.
Dr. Gauthier was the first immunotherapy clinical fellow to serve in a joint Immunotherapy Integrated Research Center (IIRC) program in clinical and laboratory research.
We make promising new treatments available to you through studies called clinical trials led by Fred Hutch doctors. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our Fred Hutch doctors conduct ongoing research to improve standards of patient care. Their work is evaluated by other doctors and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch provider has written.
Our providers are often asked to give their medical expertise for press and news publications. Read articles by or about this Fred Hutch provider.
SCCA's Jordan Gauthier, MD, MSc, was interviewed by CURE about new National Comprehensive Cancer Network CAR-T therapy guidelines for patients.
SCCA’s Jordan Gauthier, MD, discussed recent NCCN Guidelines for Patients on CAR-T Therapy Side Effects with Onco’Zine.
Your care team
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.